Human Epilepsy Project 3: Newly Diagnosed Idiopathic Generalized Epilepsy

Brief description of study

The purpose of this research study is to identify factors that can predict how patients with idiopathic generalized epilepsy will do on a given seizure medication, whether they will have side effects, and whether they will have more seizures. These factors are called biomarkers. Biomarkers are an indicator of a disease or pathology.

Clinical Study Identifier: s19-01030

ClinicalTrials.gov Identifier: NCT05374928

Principal Investigator: Christopher Elder.

Other Investigators: Jacqueline A French, Orrin Devinsky.

Contact the research team to learn more about this study.

Your Email

Not a valid e-mail address

Please Provide Email Address

First Name

First name is mandatory

Last Name

Your Phone

Please provide phone number

Invalid phone number

Valid phone number

Comments

Send Confirmation of This To Me

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Clinical Research Studies